scholarly journals SP680FRACTURE INCIDENCE AND POST FRACTURE MORTALITY IN ENGLISH AND NEW YORK STATE KIDNEY TRANSPLANT RECIPIENTS: A POPULATION LEVEL COMPARATIVE STUDY

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i321-i321
Author(s):  
Julia Arnold ◽  
Jemma Mytton ◽  
Felicity Evison ◽  
Adnan Sharif ◽  
Charles Ferro
2003 ◽  
Vol 35 (7) ◽  
pp. 2614-2616 ◽  
Author(s):  
T Said ◽  
M.R.N Nampoory ◽  
M.A Haleem ◽  
M.P Nair ◽  
K.V Johny ◽  
...  

2020 ◽  
Vol 31 (6) ◽  
pp. 1150-1156 ◽  
Author(s):  

BackgroundThe novel SARS-CoV-2 virus has caused a global pandemic of coronavirus disease 2019 (COVID-19). Although immunosuppressed individuals are thought to be at an increased risk of severe disease, little is known about their clinical presentation, disease course, or outcomes.MethodsWe report 15 kidney transplant recipients from the Columbia University kidney transplant program who required hospitalization for confirmed COVID-19, and describe their management, clinical course, and outcomes.ResultsPatients presented most often with a fever (87%) and/or cough (67%). Initial chest x-ray most commonly showed bilateral infiltrates, but 33% had no acute radiographic findings. Patients were managed with immunosuppression reduction and the addition of hydroxychloroquine and azithromycin. Although 27% of our patients needed mechanical ventilation, over half were discharged home by the end of follow-up.ConclusionsKidney transplant recipients with COVID-19 have presentations that are similar to that of the general population. Our current treatment protocol appears to be associated with favorable outcomes, but longer follow-up of a larger cohort of patients is needed.


Author(s):  
Nathan Mann ◽  
James Nonnemaker ◽  
Kevin Davis ◽  
LeTonya Chapman ◽  
Jesse Thompson ◽  
...  

Receiving smoking cessation services from telephone quitlines significantly increases quit success compared with no intervention or other quitting methods. To affect population-level smoking, quitlines must provide a sufficient proportion of smokers with effective interventions. Nationally, quitlines reach around 1% of adult smokers annually. From 2011 through 2016, the average annual reach of the New York State Smokers’ Quitline (NYSSQL) was 2.9%. We used data on the reach and cessation outcomes of NYSSQL to estimate its current impact on population-level smoking prevalence and to estimate how much reach would have to increase to achieve population-level smoking prevalence reductions. We estimate NYSSQL is associated with a 0.02 to 0.04 percentage point reduction in smoking prevalence in New York annually. If NYSSQL achieved the recommended annual reach of 8% (CDC Best Practices) and 16% (NAQC), state-level prevalence would decrease by an estimated 0.07–0.12 and 0.13–0.24 percentage points per year, respectively. To achieve those recommended levels of reach, NYSSQL would need to provide services to approximately 3.5 to 6.9 times more smokers annually. Given their reach, quitlines are limited in their ability to affect population-level smoking. Increasing quitline reach may not be feasible and would likely be cost-prohibitive. It may be necessary to re-think the role of quitlines in tobacco control efforts. In New York, the quitline is being integrated into larger efforts to promote cessation through health systems change.


2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Dina Hoefer ◽  
Bryan Cherry ◽  
Marilyn Kacica ◽  
Kristi McClamroch ◽  
Kimberly Kilby

Introduction. Surveillance for laboratory-confirmed influenza-associated deaths in children is used to monitor the severity of influenza at the population level and to inform influenza prevention and control policies. The goal of this study was to better estimate pediatric influenza mortality in New York state (NYS). Methods. Death certificate data were requested for all passively reported deaths and any pneumonia and influenza (P&I) coded pediatric deaths occurring between October 2004 and April 2010, excluding New York City (NYC) residents. A matching algorithm and capture-recapture analysis were used to estimate the total number of influenza-associated deaths among NYS children. Results. Thirty-four laboratory-confirmed influenza-associated pediatric deaths were reported and 67 death certificates had a P&I coded death; 16 deaths matched. No laboratory-confirmed influenza-associated death had a pneumonia code and no pneumonia coded deaths had laboratory evidence of influenza infection in their medical record. The capture-recapture analysis estimated between 38 and 126 influenza-associated pediatric deaths occurred in NYS during the study period. Conclusion. Passive surveillance for influenza-associated deaths continues to be the gold standard methodology for characterizing influenza mortality in children. Review of death certificates can complement but not replace passive reporting, by providing better estimates and detecting any missed laboratory-confirmed deaths.


2003 ◽  
Vol 18 (4) ◽  
pp. 809-813 ◽  
Author(s):  
A. Yango ◽  
P. Morrissey ◽  
A. Zanabli ◽  
J. Beaulieu ◽  
D. Shemin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document